Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Semaglutide’s Success Could Usher in a “New Dawn” for Obesity Treatment

Semaglutide’s Success Could Usher in a “New Dawn” for Obesity Treatment This Medical News article discusses the physiology of weight regulation and obesity—and how new antiobesity drugs like semaglutide will target those pathways for safer, more effective treatment. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Semaglutide’s Success Could Usher in a “New Dawn” for Obesity Treatment

JAMA , Volume 326 (2) – Jul 13, 2021

Loading next page...
 
/lp/american-medical-association/semaglutide-s-success-could-usher-in-a-new-dawn-for-obesity-treatment-0TCArdtBaN

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2021.10307
Publisher site
See Article on Publisher Site

Abstract

This Medical News article discusses the physiology of weight regulation and obesity—and how new antiobesity drugs like semaglutide will target those pathways for safer, more effective treatment.

Journal

JAMAAmerican Medical Association

Published: Jul 13, 2021

There are no references for this article.